Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Ergomed launches Rare Disease Innovation Center

ERGOMED plc a leading Clinical Research Organization focused on rare disease drug development today announced the establishment of its Rare Disease Innovation Center™. Rare diseases...

WHO includes oral antiviral molnupiravir in Covid-19 treatment guidelines

WHO has updated its living guidelines on COVID-19 therapeutics to include a conditional recommendation on molnupiravir, a new antiviral medicine. This is the first oral...

Roche teams up with research institutions for new Alzheimer’s trial

Roche announced a new Phase III Alzheimer’s disease prevention trial SKYLINE with gantenerumab, an investigational anti-amyloid antibody that is administered subcutaneously. Roche intends to...

World leaders, experts call for action to protect environment from pollution

World leaders and experts today called for global action to reduce antimicrobial pollution recognising this as critical to combatting rising levels of drug resistance...

Pfizer pulls blood pressure med in Canada on carcinogen fears

Pfizer is pulling 15 lots of its long-acting blood pressure med Inderal from Canadian shelves, citing unacceptable nitrosamine levels across a range of product...

Association of Young Nephrologists founded

This year’s World Congress of Nephrology, WCN’22, has taken place in Kuala Lumpur (Malaysia). Reports from Russian experts were presented in the section Raising...
spot_img

Expert Articles

spot_img